1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pathogenicity of mutation analyzer (PathoMAN): A fast automation of germline genonnic variant curation in clinical sequencing
    Meeting Abstract

    Joseph, V.; Ravichandran, V.; Offit, K.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Brain metastases (BM) in pancreatic ductal adenocarcinoma (PDAC): Clinical and molecular characteristics
    Meeting Abstract

    Jordan, E.; Kaley, T. J.; Capanu, M.; Estrella, H.; Leach, S. D.; Basturk, O.; Klimstra, D. S.; Allen, P. J.; Berger, M. F.; Yu, K. H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • RASA1 and NF1 co-mutated non-small cell lung carcinomas: Cancer genomic data and evaluation of sensitivity to MEK inhibition
    Meeting Abstract

    Hayashi, T.; Desmeules, P.; Smith, R.; Drilon, A. E.; Somwar, R.; Ladanyi, M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 1B of ibrutinib and high-dose methotrexate for recurrent/refractory CNS lymphoma
    Meeting Abstract

    Grommes, C.; Stone, J.; Nolan, C.; Tsyvkin, E.; Wolfe, J.; Mellinghoff, I. K.; DeAngelis, L. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Clinical benefit and toxicity of nivolumab plus ipilimumab in patients with advanced melanoma previously treated with checkpoint blockade inhibitors
    Meeting Abstract

    Friedman, C. F.; Wolchok, J. D.; Postow, M. A.; Shoushtari, A. N.; Callahan, M. K.; Momtaz, P.; Chapman, P. B.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • YES1 amplification as a mechanism of acquired resistance (AR) to EGFR tyrosine kinase inhibitors (TKIs) identified by a transposon mutagenesis screen and clinical genomic testing
    Meeting Abstract

    Fan, P. D.; Narzisi, G.; Jayaprakash, A.; Venturini, E.; Robine, N.; Smibert, P.; Germer, S.; Jordan, E.; Wang, L.; Jungbluth, A. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Circulating tumor cells and genomic profiling of patients with ERBB2 mutant, HER2 non-amplified metastatic breast cancer treated with neratinib
    Meeting Abstract

    D'Souza, A.; Shishedo, S.; Spicer, D. V.; Welter, L.; Jiang, Y.; Hyman, D. M.; Solit, D. B.; Ma, C. X.; Bose, R.; Cutler, R. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Molecular landscape of fibrolamellar carcinoma (FLC): Beyond the DNAJB1-PRKACA chimera
    Meeting Abstract

    El Dika, I. H.; Capanu, M.; Berger, M. F.; Arcila, M. E.; Benayed, R.; Harding, J. J.; Rusek, M.; Valentino, E.; O'Reilly, E. M.; Saltz, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A situation where hepatocellular carcinoma (HCC) may be more common in women than men: Clinical and genetic patterns of non risk-factored HCC
    Meeting Abstract

    El Dika, I. H.; Harding, J. J.; Capanu, M.; Berger, M. F.; Rebibo, D.; Rusek, M.; Chou, J. F.; O'Reilly, E. M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer
    Meeting Abstract

    Creasy, J. M.; Sadot, E.; Koerkamp, B. G.; Chou, J. F.; Gonen, M.; Kemeny, N. E.; Cercek, A.; Saltz, L.; Balachandran, V. P.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save